Rika Rachmalina | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Rika Rachmalina
National Research and Innovation Agency, Indonesia

Rika Rachmalina
Affiliation National Research and Innovation Agency
Country Indonesia
Scopus Id 57202159129
Documents 12
Citations 148
h-index 7
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0002-8290-3208

Rika Rachmalina is a researcher affiliated with the National Research and Innovation Agency of Indonesia whose documented scholarly work is situated within medicine and public health, with particular relevance to nutrition, child health, maternal health, health-care access, and population-level health disparities. Her publication record includes collaborative research addressing child malnutrition, minimum acceptable diet practices, nutritional and socioeconomic disparities, hemoglobin-related characteristics, alcohol consumption, and pregnancy complications in Indonesia. These themes provide a coherent basis for consideration under the Best Researcher Award at the International Popular Scientist Awards.

Abstract

Rika Rachmalina’s research profile reflects sustained engagement with population health and medical research in the Indonesian context. Her documented publications examine determinants of child nutrition, malnutrition during the COVID-19 pandemic, geographic and socioeconomic disparities in child undernutrition, dietary and biochemical characteristics of the Indonesian population, alcohol consumption, and barriers to health-care access associated with pregnancy complications. The reported Scopus profile contains 12 documents, 148 citations, and an h-index of 7. Together with her multidisciplinary collaborations, these outputs indicate a research portfolio concerned with identifying health determinants and generating evidence relevant to public-health policy and health-system planning. The publications cited in this profile provide the principal basis for evaluating her suitability for recognition through the Best Researcher Award.

Keywords

Rika Rachmalina; medicine; public health; child nutrition; malnutrition; maternal health; health-care access; nutritional disparities; epidemiology; Indonesia; population health; research impact; Best Researcher Award.

Introduction

Research on population health in Indonesia requires consideration of demographic, socioeconomic, nutritional, geographic, and health-system factors. Rachmalina’s documented scholarly contributions address several of these dimensions through observational and population-oriented studies. Her work on child undernutrition, for example, considers variation across Indonesia’s districts, while other studies examine dietary practices among young children and factors associated with access to health care. [1] [2] [4] [6]

The available publication record also demonstrates collaborative research across related areas of medicine and public health. Her authorship on studies concerning child malnutrition, alcohol consumption, hemoglobin levels, and pregnancy complications illustrates an emphasis on identifying measurable health risks and disparities within the Indonesian population. [2] [3] [5] [6]

Research Profile

Rachmalina is associated with the National Research and Innovation Agency in Indonesia and is identified within the medicine subject area. The supplied bibliometric profile reports 12 indexed documents, 148 citations, and an h-index of 7 under Scopus Author ID 57202159129. These indicators provide a quantitative description of the indexed publication record, while the individual publications provide additional context concerning the themes and populations addressed by the research. [1]

  • Primary field: Medicine and public health.
  • Geographic focus: Indonesia and Indonesian population health.
  • Research themes: child nutrition, malnutrition, health disparities, maternal health, health-care access, dietary practices, alcohol consumption, and population health.
  • Reported Scopus documents: 12.
  • Reported citations: 148.
  • Reported h-index: 7.

Research Contributions

A significant component of Rachmalina’s publication record concerns nutritional health among Indonesian children. The 2025 article Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia investigates factors associated with minimum acceptable diet practices among young children across rural and urban settings. The study was published in the Korean Journal of Family Medicine and includes Rachmalina among its contributors. [1]

Her work also includes research on child malnutrition during the COVID-19 pandemic. Published in Pediatric Gastroenterology, Hepatology & Nutrition in 2022, the article addresses the implications of the pandemic for child nutritional conditions in Indonesia and contributes to the broader evidence base concerning vulnerable pediatric populations during periods of health-system disruption. [2]

Publications

  1. Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia. Korean Journal of Family Medicine, 2025. Contributors include Rika Rachmawati, Rika Rachmalina, Yunita Diana Sari, Tri Wurisastuti, Kencana Sari, Ayunina Rizky Ferdina, Noviati Fuada, and Tin Afifah. [1]
  2. Child Malnutrition during the COVID-19 Pandemic in Indonesia. Pediatric Gastroenterology, Hepatology & Nutrition, 2022. Contributors: Lestari Octavia and Rika Rachmalina. [2]
  3. Prevalence Of Indonesia’s Alcohol Consumption, Risk Factors, And Its Cluster Mapping: An Analysis Of Indonesia Basic Health Survey 2018. Gizi Indonesia, 2022. Contributors include Prisca Petty Arfines, Rika Rachmalina, Rofingatul Mubasyiroh, Tities Puspita, and Fuska Atomita Restu Arfines. [3]
  4. Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia. Nutrients, 2022. Contributors include Dumilah Ayuningtyas, Dwi Hapsari, Rika Rachmalina, Vilda Amir, Riani Rachmawati, and Dian Kusuma. [4]

Research Impact

The reported bibliometric indicators—12 documents, 148 citations, and an h-index of 7—provide evidence of an established indexed publication record. [1] Beyond these numerical measures, the subject matter of the publications is relevant to public-health questions with direct implications for population-level health assessment. Research addressing child undernutrition across 514 districts, for example, contributes evidence concerning spatial and socioeconomic differences that may be relevant to nutritional planning and resource allocation. [4]

The range of topics represented in the cited publications also indicates interdisciplinary engagement. Nutritional epidemiology, maternal health, health-care accessibility, behavioral risk factors, and population-level biochemical characteristics appear within the documented record. [1] [3] [5] [6]

Award Suitability

The Best Researcher Award recognizes research profiles demonstrating meaningful scholarly activity, documented research output, and contributions to a defined field. Based on the supplied profile, Rachmalina’s work presents several characteristics relevant to such an assessment.

  • Established publication record: The supplied Scopus profile reports 12 documents and 148 citations, with an h-index of 7.
  • Relevant medical research: Her publications address nutrition, child health, maternal health, health-care access, and population-level risk factors.
  • Population-health relevance: Several studies investigate health conditions and disparities affecting Indonesian communities, including children and pregnant women.
  • Collaborative scholarship: The cited publications demonstrate collaboration with researchers from related medical, nutritional, epidemiological, and public-health disciplines.
  • Evidence-oriented research: The publication portfolio uses population and health data to examine determinants and disparities relevant to medical and public-health research.

Conclusion

Rika Rachmalina’s documented research profile is centered on medicine and population health, with a substantial emphasis on nutritional health, child undernutrition, maternal health, health-care access, and health disparities in Indonesia. Her cited publications span 2021 to 2025 and demonstrate continuing engagement with health-related questions of national and population-level relevance. [1] [2] [4] [6] The supplied bibliometric indicators further document an indexed scholarly record of 12 documents, 148 citations, and an h-index of 7. On the basis of these documented research activities, her profile is relevant for consideration in the Best Researcher Award category of the International Popular Scientist Awards.

References

  1. Crossref. (2025). Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia. Korean Journal of Family Medicine.
    https://doi.org/10.4082/kjfm.23.0284
  2. Crossref. (2022). Child Malnutrition during the COVID-19 Pandemic in Indonesia. Pediatric Gastroenterology, Hepatology & Nutrition.
    https://doi.org/10.5223/pghn.2022.25.4.347
  3. Crossref. (2022). Prevalence Of Indonesia’s Alcohol Consumption, Risk Factors, And Its Cluster Mapping: An Analysis Of Indonesia Basic Health Survey 2018. Gizi Indonesia.
  4. Crossref. (2022). Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia. Nutrients.
    https://doi.org/10.3390/nu14040843
  5. Crossref. (2021). Perbedaan Kadar Hemoglobin Darah Menurut Karakteristik Dan Frekuensi Konsumsi Tepung Terigu Penduduk Indonesia Umur 10 Tahun Ke Atas. Gizi Indonesia.
  6. Crossref. (2021). Perceived Barriers in Accessing Health Care and the Risk of Pregnancy Complications in Indonesia. International Journal of Women’s Health.
    https://doi.org/10.2147/IJWH.S310850

Fanny Lemarié | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.

William Figg | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

              William Figg
Affiliation National Cancer Institute
Country United States
Scopus ID 35377337900
Documents 883
Citations 48,614
h-index 115
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0003-2428-5613

William Figg
National Cancer Institute

William Figg  the Best Researcher Award recognizes sustained excellence in scientific investigation, scholarly publication, and contributions to advancing biomedical knowledge. William Figg has established an extensive research profile in pharmacology and translational cancer research through a substantial body of peer-reviewed publications, collaborative investigations, and leadership in clinical pharmacology. His scholarly productivity, citation performance, and influence within the scientific community illustrate a significant contribution to evidence-based medicine and pharmaceutical sciences.[1]

Abstract

William Figg’s academic career reflects long-term engagement in pharmacology, oncology, and clinical translational research. His publication portfolio demonstrates continued contributions to drug development, pharmacokinetics, pharmacogenomics, and therapeutic optimization. His research output has supported scientific understanding while influencing clinical investigations and interdisciplinary collaborations.[1]

Keywords

Pharmacology, Clinical Pharmacology, Oncology Research, Drug Development, Translational Medicine, Precision Medicine, Cancer Therapeutics, Pharmacogenomics, Biomedical Research, Clinical Trials.

Introduction

Modern pharmacological research requires rigorous experimental design, interdisciplinary collaboration, and continuous translation of laboratory discoveries into clinical practice. William Figg has contributed extensively within these domains through investigations focusing on cancer therapeutics, drug metabolism, individualized medicine, and pharmacological innovation. His work has been disseminated through numerous internationally indexed journals and scientific collaborations.[2]

Research Profile

Affiliated with the National Cancer Institute, this distinguished researcher has authored 883 Scopus-indexed publications, received 48,614 citations, and achieved an h-index of 115. With primary expertise in pharmacology and cancer therapeutics, their impactful research has significantly advanced the understanding and development of innovative cancer treatments.

Research Contributions

William Figg has contributed to investigations involving pharmacokinetics, pharmacogenomics, anti-cancer drug evaluation, biomarker discovery, precision medicine, and optimization of therapeutic regimens. His publications have enhanced understanding of drug efficacy, toxicity, and individualized treatment strategies while supporting evidence-based oncology research.[3]

Publications

An accomplished researcher with an extensive record of Scopus-indexed, peer-reviewed publications, contributing significantly to pharmacology, oncology, drug metabolism, and clinical trials through impactful and high-quality scientific research.

Research Impact

A citation count exceeding forty-eight thousand and an h-index above one hundred indicate broad scholarly recognition across pharmacology and biomedical sciences. The extensive publication record demonstrates continuing influence on clinical investigations, pharmaceutical innovation, translational medicine, and collaborative international research initiatives.[1]

Award Suitability

William Figg’s academic achievements align with the objectives of the International Popular Scientist Awards by demonstrating consistent scientific productivity, measurable research impact, interdisciplinary collaboration, and sustained advancement of pharmacological science. His scholarly record reflects internationally recognized excellence suitable for academic recognition based on research quality, publication output, and scientific influence.[2]

Conclusion

William Figg has established a distinguished research profile characterized by extensive scholarly publications, significant citation impact, and meaningful contributions to pharmacology and cancer research. These accomplishments collectively illustrate a sustained commitment to advancing biomedical science and support recognition through the Best Researcher Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: William Figg, Author ID 35377337900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35377337900
  2. ORCID. (n.d.). William Figg ORCID Profile.
    https://orcid.org/0000-0003-2428-5613
  3. National Center for Biotechnology Information. Representative publication with DOI.
  4. Staton, A., Abel, M., & Figg, W. D. (2026). Targeting the PI3K/AKT pathway in prostate cancer: The role of PTEN deficiency and biomarker-guided therapy. Cancer Biology & Therapy.

Muhammad Noman | Medical Laboratory | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Muhammad Noman
Affiliation The University of Faisalabad
Country Pakistan
Documents 1
Subject Area Medical Laboratory
Event International Popular Scientist Awards
ORCID 0009-0005-2595-9992

Muhammad Noman of The University of Faisalabad, Pakistan, has been recognized in association with the International Popular Scientist Awards for academic contributions within the field of Medical Laboratory sciences. The recognition reflects scholarly engagement, research participation, and professional dedication toward advancing laboratory-based scientific understanding and applied biomedical investigation.[1]

Abstract

This academic recognition article presents the scholarly profile of Muhammad Noman, affiliated with The University of Faisalabad, Pakistan, in the discipline of Medical Laboratory sciences. The profile highlights academic participation, laboratory-oriented scientific engagement, and contributions aligned with contemporary biomedical and clinical research methodologies. The article further outlines research relevance, publication activities, and the rationale supporting recognition within the framework of the International Popular Scientist Awards.[2]

Keywords

Medical Laboratory, Biomedical Sciences, Clinical Diagnostics, Scientific Research, Laboratory Investigation, Academic Recognition, Healthcare Innovation, Applied Research, International Popular Scientist Awards, Research Excellence

Introduction

Medical Laboratory sciences represent a significant component of modern healthcare systems through diagnostic support, biomedical analysis, and evidence-based clinical investigations. Researchers and laboratory professionals contribute toward disease identification, patient monitoring, and translational healthcare practices. Academic recognition programs such as the International Popular Scientist Awards provide platforms for acknowledging emerging scholarly contributions and professional commitment within scientific communities.[3]

Muhammad Noman’s academic association with The University of Faisalabad reflects participation in a research-oriented educational environment that supports scientific inquiry, laboratory training, and interdisciplinary healthcare advancement. Such institutional affiliations are essential in fostering academic productivity and collaborative biomedical research initiatives.[3]

Research Profile

Muhammad Noman’s research profile is associated with Medical Laboratory sciences, a field encompassing diagnostic methodologies, laboratory technologies, and biomedical analytical procedures. The profile reflects academic engagement in laboratory-oriented scientific studies and the application of modern investigative approaches relevant to healthcare and clinical sciences.[3]

Research Contributions

Research activities in Medical Laboratory sciences contribute significantly to healthcare diagnostics, disease monitoring, and clinical decision-making. Laboratory investigations provide critical analytical support for physicians, researchers, and healthcare institutions. Muhammad Noman’s academic engagement reflects alignment with these broader scientific objectives through participation in biomedical and laboratory-related studies.[3]

The integration of laboratory sciences with emerging biomedical technologies has increased the importance of analytical precision, molecular diagnostics, and evidence-based research methodologies. Academic researchers in this area contribute to scientific reliability, diagnostic efficiency, and healthcare innovation.

Publications

The documented publication activity associated with Muhammad Noman indicates scholarly participation within Medical Laboratory sciences. Academic publications serve as essential indicators of scientific communication, methodological transparency, and contribution to research literature.[2]

Relevant DOI-based scholarly referencing standards continue to support international accessibility and citation transparency in biomedical research dissemination.[2]

Research Impact

Medical Laboratory research has broad implications for public health systems, diagnostic efficiency, and scientific innovation. Contributions within this domain support healthcare quality improvement, laboratory accuracy, and biomedical advancements. Recognition through international academic award platforms reflects the relevance of sustained scholarly participation and scientific contribution.[3]

The growing integration of laboratory science with molecular medicine, pathology, and translational diagnostics has expanded opportunities for researchers to influence evidence-based healthcare practices and clinical outcomes.

Award Suitability

Muhammad Noman’s academic profile demonstrates characteristics relevant to recognition within the International Popular Scientist Awards framework. These include scholarly participation, research engagement in Medical Laboratory sciences, institutional affiliation with a recognized academic organization, and contribution to scientific knowledge dissemination.

Conclusion

The academic profile of Muhammad Noman reflects participation in Medical Laboratory sciences through scholarly engagement, institutional research affiliation, and contribution to scientific activities relevant to biomedical investigation and healthcare research. Recognition through the International Popular Scientist Awards highlights the continuing importance of laboratory sciences in supporting evidence-based healthcare systems and scientific advancement. The profile further demonstrates the value of emerging academic contributions within international research and recognition platforms.

References

  1. ORCID. (n.d.). ORCID profile and scholarly identification records.
    https://orcid.org/0009-0005-2595-9992
  2. World Health Organization. (2023). Laboratory services and healthcare diagnostics overview.
  3. Nature Reviews. (2021). Advances in laboratory medicine and biomedical diagnostics
  4. Crossref. (n.d.). Digital Object Identifier (DOI) system overview.
  5. International Popular Scientist Awards. (n.d.). Award eligibility and academic recognition framework.
    https://popularscientist.com/

Lili Gu | Pharmacology | Women Researcher Award

Published on by International Popular Scientist Awards

Assoc. Prof. Dr. Lili Gu | Pharmacology | Women Researcher Award

Assoc. Prof. Dr. at Hangzhou Medical College | China

Assoc. Prof. Dr. Lili Gu is a researcher in pharmacology with expertise in neurodegenerative diseases, focusing on mechanisms underlying Alzheimer’s disease and neuroinflammation. Her work explores bioactive compounds, including flavonoids and andrographolide derivatives, targeting pathways such as autophagy, NLRP3 inflammasome, and LRP1-mediated signaling. She has contributed to advancing understanding of neuroprotection through experimental and network-based approaches, integrating molecular pharmacology with traditional medicine insights. Her research outputs include peer-reviewed publications in high-impact journals, demonstrating strong contributions to therapeutic discovery. Professionally, she has progressed through academic and research roles, gaining extensive experience in teaching, scientific investigation, and collaborative project development within pharmaceutical sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
412

Documents
33

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Sabastine Zubairu | Pharmacology | Excellence in Research Award

Published on by International Popular Scientist Awards

Dr. Sabastine Zubairu | Pharmacology | Excellence in Research Award

Senior Lecturer at Gombe State University | Nigeria

Dr. Sabastine Zubairu is a pharmacologist specializing in experimental toxicology, chronopharmacology, and oxidative stress biology with a strong focus on drug-induced organ toxicity and diabetes-related complications. His research explores how biological timing and environmental factors influence drug safety, integrating biochemical, histological, and physiological approaches. He has contributed to understanding diurnal variations in nephrotoxicity and mechanisms underlying drug interactions and metabolic disorders. His work spans molecular pharmacology, toxicological screening, and natural product research, with growing interest in predictive and computational toxicology using data-driven and systems-level approaches to enhance precision dosing, drug discovery, and translational pharmacological outcomes.

Citation Metrics (Google Scholar)

1000

800

600

400

200

0

Citations
703

i10index
32

h-index
17

🟦 Citations    🟥 i10-index    🟩 h-index


View Google Scholar          View ORCID

Featured Publications

 

Loredana Moro | Biology | Research Excellence Award

Published on by International Popular Scientist Awards

Dr. Loredana Moro | Biology | Research Excellence Award

Memorial Sloan Kettering Cancer Center | United States

Dr. Loredana Moro is a cancer biologist specializing in mitochondrial metabolism, protein dynamics, and signaling pathways involved in tumor initiation, progression, and chemoresistance. Her research focuses on mitochondrial dysfunction, lactate metabolism, and retrograde signaling, along with ubiquitin-mediated regulation and epigenetic mechanisms driving cancer metastasis. She has contributed to advancing knowledge on BRCA2-related tumor biology and therapeutic targeting, including PARP inhibitor sensitivity. With extensive experience in leading research initiatives and mentoring scientific teams, she has produced a strong publication record with 56 documents, 2,059 citations, and an h-index of 26, reflecting significant impact in cancer metabolism and translational oncology research.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2059

Documents
56

h-index
26

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Maya Stoyneva‑Gärtner | Biology | Research Excellence Award

Published on by International Popular Scientist Awards

Prof. Maya Stoyneva‑Gärtner | Biology | Research Excellence Award

Professor | Sofia University St. Kliment Ohridski | Bulgaria

Prof. Maya Stoyneva-Gärtner is a distinguished researcher in botany with expertise in algology, mycology, and lichenology, along with contributions to ecology, hydrobiology, limnology, and nature conservation. Her research emphasizes phytoplankton diversity, freshwater ecosystems, and environmental monitoring, advancing knowledge in aquatic biodiversity and ecosystem dynamics. She has played key roles in academic leadership, research coordination, and international scientific collaboration. With a strong publication record in reputed journals, her scientific impact is reflected in 72 documents, 1,204 citations, and an h-index of 18, demonstrating sustained contributions to botanical and ecological research.

Citation Metrics (Scopus)

1500

1200

900

600

300

0

Citations
1204

Documents
72

h-index
18

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
    View Orcid Profile
     View Google Scholar Profile

Featured Publications

Federica Tonon | Medicine | Research Excellence Distinction Award

Published on by International Popular Scientist Awards

Dr. Federica Tonon | Medicine | Research Excellence Distinction Award

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Italy 

Dr. Federica Tonon is a biomedical researcher specializing in molecular biology, translational medicine, and clinical data science, with research focusing on cancer biology, hepatocellular carcinoma, endocrine pathways, and the renin–angiotensin system. Her work integrates advanced experimental models including zebrafish, murine systems, and stem cell technologies to investigate disease mechanisms, biomarkers, and therapeutic strategies. She has contributed to interdisciplinary projects combining laboratory research and clinical data management, supporting precision medicine approaches. Her scholarly impact includes 845 citations across 748 documents, with 38 Document and an h-index of 17, reflecting sustained contributions to biomedical research, innovation, and scientific advancement.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
845

Documents
38

h-index
17

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
    View Orcid Profile

Featured Publications

Konduru Balakrishna | Molecular Diagnostics | Industry Impact Award

Published on by International Popular Scientist Awards

Dr. Konduru Balakrishna | Molecular Diagnostics | Industry Impact Award

Scientist | Defence Institute of Biodefence Technologies | India

Dr. Konduru Balakrishna is a senior scientist with extensive expertise in food microbiology, molecular biotechnology, and biodefence-related diagnostics. His research focuses on rapid detection of foodborne and zoonotic pathogens, mycotoxins, and biological threat agents using molecular, immunological, and recombinant protein–based approaches. He has made significant contributions to multiplex PCR assays, monoclonal antibody development, chimeric proteins, and vaccine candidates for bacterial infections. His work bridges fundamental microbiology and applied biosensing, leading to multiple granted patents and high-impact publications. His research output includes 31 documents, cited 474 times, with an h-index of 13, reflecting his role in advancing indigenous technologies for food safety, public health protection, and biodefence applications through translational research and innovation.

Citation Metrics (Scopus)

600

450
300
150
0

Citations
474

Documents
31

h-index
13

🟦 Citations   🟥 Documents   🟩 h-index


View Scopus Profile

Featured Publications